Submitted by Anonymous (not verified) on 27 January 2026 - 9:08
Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 28, Status: Authorised
Source: